mika AI Closes $6.

Integral

We believe businesses should focus on what matters most – growing their business. We are the trusted partner for businesses when it comes to accounting, taxation & payroll services.

Depotcharge

At evolve, we believe the future of commercial fleet charging will be at the depot. And that depot charging will be shared and smart. With depotcharge, we’re building Europe’s leading marketplace for shared depot charging – connecting carriers with depot operators to provide electric fleets with access to exclusive, cost-effective EV charging while creating new revenue streams for depot operators.

ARTCLINE GmbH

ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to realize our vision. Together with scientists and partners, we focus our research activities on the root causes and correlations of sepsis. For many years, the founders and the team of ARTCLINE GmbH have been successfully involved in the transfer of medical inventions from university research to industrial application. We have an extensive network and long standing experience in the development and successful marketing of medical devices and drugs.